Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Endoscopy, Gastrointestinal | 30 | 2025 | 888 | 5.580 |
Why?
|
Colonic Polyps | 17 | 2024 | 556 | 4.640 |
Why?
|
Artificial Intelligence | 30 | 2025 | 2659 | 4.470 |
Why?
|
Gastroenterology | 14 | 2024 | 594 | 3.520 |
Why?
|
Colonoscopy | 26 | 2024 | 1406 | 2.810 |
Why?
|
Diagnosis, Computer-Assisted | 10 | 2024 | 698 | 1.950 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 17 | 2024 | 520 | 1.950 |
Why?
|
Endoscopy, Digestive System | 6 | 2021 | 358 | 1.790 |
Why?
|
Endosonography | 13 | 2024 | 626 | 1.580 |
Why?
|
Capsule Endoscopy | 2 | 2025 | 107 | 1.510 |
Why?
|
Pancreatic Diseases | 5 | 2021 | 353 | 1.180 |
Why?
|
Adenoma | 7 | 2022 | 2152 | 1.010 |
Why?
|
Conscious Sedation | 4 | 2016 | 531 | 0.970 |
Why?
|
Polyps | 2 | 2023 | 200 | 0.920 |
Why?
|
Juniperus | 1 | 2023 | 3 | 0.880 |
Why?
|
Endoscopy | 7 | 2023 | 1841 | 0.860 |
Why?
|
Deep Sedation | 4 | 2020 | 118 | 0.840 |
Why?
|
Duodenoscopes | 3 | 2020 | 43 | 0.790 |
Why?
|
Jaw | 1 | 2022 | 94 | 0.760 |
Why?
|
Privacy | 1 | 2023 | 233 | 0.740 |
Why?
|
Confidentiality | 2 | 2023 | 607 | 0.710 |
Why?
|
Colorectal Neoplasms | 10 | 2024 | 6942 | 0.710 |
Why?
|
Monitoring, Intraoperative | 3 | 2016 | 936 | 0.690 |
Why?
|
Surgical Instruments | 2 | 2023 | 377 | 0.690 |
Why?
|
Gastrointestinal Diseases | 4 | 2024 | 1203 | 0.660 |
Why?
|
Anesthetics, Intravenous | 2 | 2014 | 397 | 0.650 |
Why?
|
Colonography, Computed Tomographic | 1 | 2021 | 170 | 0.650 |
Why?
|
Pancreatitis | 7 | 2024 | 1087 | 0.630 |
Why?
|
Benchmarking | 3 | 2024 | 1052 | 0.620 |
Why?
|
Intestine, Small | 1 | 2025 | 1214 | 0.610 |
Why?
|
Barrett Esophagus | 3 | 2019 | 494 | 0.600 |
Why?
|
Disease Transmission, Infectious | 2 | 2020 | 560 | 0.590 |
Why?
|
Drainage | 6 | 2020 | 1179 | 0.580 |
Why?
|
Conflict of Interest | 1 | 2021 | 556 | 0.520 |
Why?
|
Pancreatitis, Acute Necrotizing | 2 | 2008 | 174 | 0.510 |
Why?
|
Cholangiography | 1 | 2014 | 182 | 0.460 |
Why?
|
Pneumatosis Cystoides Intestinalis | 1 | 2014 | 31 | 0.450 |
Why?
|
Delphi Technique | 5 | 2024 | 893 | 0.450 |
Why?
|
Cross Infection | 2 | 2020 | 1427 | 0.450 |
Why?
|
Choledocholithiasis | 3 | 2024 | 50 | 0.440 |
Why?
|
Common Bile Duct | 1 | 2014 | 106 | 0.440 |
Why?
|
Hyperbaric Oxygenation | 1 | 2014 | 167 | 0.420 |
Why?
|
Humans | 114 | 2025 | 765968 | 0.420 |
Why?
|
Anesthesia, General | 3 | 2023 | 1172 | 0.410 |
Why?
|
Pancreas | 5 | 2019 | 1700 | 0.410 |
Why?
|
Pancreatic Ducts | 1 | 2014 | 332 | 0.390 |
Why?
|
Intestinal Polyposis | 1 | 2012 | 42 | 0.380 |
Why?
|
Propofol | 3 | 2013 | 606 | 0.350 |
Why?
|
Stents | 7 | 2024 | 3213 | 0.350 |
Why?
|
Scattering, Radiation | 1 | 2021 | 482 | 0.330 |
Why?
|
Catheterization | 1 | 2014 | 1425 | 0.320 |
Why?
|
Choristoma | 1 | 2010 | 206 | 0.310 |
Why?
|
Research Design | 3 | 2024 | 6209 | 0.310 |
Why?
|
Pancreatic Pseudocyst | 2 | 2019 | 113 | 0.310 |
Why?
|
Pancreatic Neoplasms | 5 | 2022 | 5444 | 0.310 |
Why?
|
Duodenum | 1 | 2012 | 495 | 0.310 |
Why?
|
Computers | 2 | 2021 | 588 | 0.300 |
Why?
|
Clinical Competence | 2 | 2024 | 4863 | 0.290 |
Why?
|
Algorithms | 8 | 2025 | 14071 | 0.290 |
Why?
|
Stomach | 1 | 2012 | 699 | 0.280 |
Why?
|
Fiducial Markers | 2 | 2021 | 134 | 0.260 |
Why?
|
Carbapenems | 1 | 2007 | 125 | 0.260 |
Why?
|
Hypnotics and Sedatives | 2 | 2013 | 1191 | 0.250 |
Why?
|
Digestive System Diseases | 2 | 2020 | 151 | 0.250 |
Why?
|
Consensus | 5 | 2024 | 3202 | 0.250 |
Why?
|
Carcinoma, Pancreatic Ductal | 2 | 2022 | 1758 | 0.250 |
Why?
|
Stomach Neoplasms | 2 | 2019 | 1471 | 0.250 |
Why?
|
Catheters, Indwelling | 1 | 2008 | 438 | 0.250 |
Why?
|
Diarrhea | 1 | 2012 | 1316 | 0.240 |
Why?
|
Arrhythmias, Cardiac | 2 | 2014 | 2247 | 0.240 |
Why?
|
Anesthesia | 1 | 2016 | 1590 | 0.230 |
Why?
|
Prospective Studies | 17 | 2023 | 54802 | 0.230 |
Why?
|
Catheterization, Peripheral | 1 | 2008 | 349 | 0.230 |
Why?
|
Cholangitis | 2 | 2024 | 110 | 0.220 |
Why?
|
Catheter Ablation | 3 | 2016 | 2788 | 0.220 |
Why?
|
Mycoses | 1 | 2007 | 389 | 0.220 |
Why?
|
Anesthetics | 2 | 2023 | 525 | 0.210 |
Why?
|
Agrin | 2 | 2000 | 75 | 0.210 |
Why?
|
Pancreatitis, Chronic | 2 | 2017 | 282 | 0.200 |
Why?
|
Image Interpretation, Computer-Assisted | 3 | 2020 | 3356 | 0.200 |
Why?
|
Carcinoma | 1 | 2014 | 2312 | 0.200 |
Why?
|
Coronavirus Infections | 4 | 2020 | 3100 | 0.200 |
Why?
|
Pneumonia, Viral | 4 | 2020 | 3223 | 0.200 |
Why?
|
Patient Satisfaction | 2 | 2014 | 3475 | 0.200 |
Why?
|
Fellowships and Scholarships | 3 | 2024 | 1135 | 0.190 |
Why?
|
Peptic Ulcer Hemorrhage | 1 | 2021 | 47 | 0.180 |
Why?
|
Academies and Institutes | 1 | 2023 | 326 | 0.180 |
Why?
|
Occupational Exposure | 1 | 2021 | 1805 | 0.180 |
Why?
|
Radiography, Interventional | 1 | 2008 | 1129 | 0.180 |
Why?
|
Endoscopes, Gastrointestinal | 1 | 2020 | 45 | 0.170 |
Why?
|
Prisons | 1 | 2002 | 178 | 0.170 |
Why?
|
Pancreatic Cyst | 1 | 2024 | 373 | 0.170 |
Why?
|
Middle Aged | 36 | 2024 | 223009 | 0.170 |
Why?
|
Intestinal Diseases | 1 | 2025 | 506 | 0.170 |
Why?
|
Aged | 31 | 2024 | 171117 | 0.170 |
Why?
|
Aged, 80 and over | 16 | 2024 | 59489 | 0.170 |
Why?
|
Adenomatous Polyps | 1 | 2020 | 109 | 0.160 |
Why?
|
Bile Ducts | 2 | 2023 | 288 | 0.160 |
Why?
|
Metals | 2 | 2020 | 710 | 0.160 |
Why?
|
Suture Techniques | 1 | 2024 | 773 | 0.160 |
Why?
|
Colon | 2 | 2023 | 1795 | 0.150 |
Why?
|
Gallbladder | 1 | 2020 | 308 | 0.150 |
Why?
|
Male | 43 | 2024 | 363698 | 0.150 |
Why?
|
Plastics | 1 | 2018 | 117 | 0.150 |
Why?
|
Risk Assessment | 6 | 2024 | 24282 | 0.150 |
Why?
|
Retrospective Studies | 18 | 2024 | 81514 | 0.150 |
Why?
|
Needles | 1 | 2021 | 460 | 0.150 |
Why?
|
Single-Blind Method | 1 | 2021 | 1589 | 0.140 |
Why?
|
Gastrointestinal Tract | 1 | 2023 | 834 | 0.140 |
Why?
|
Equipment Contamination | 1 | 2019 | 183 | 0.140 |
Why?
|
Prosthesis Implantation | 2 | 2019 | 595 | 0.140 |
Why?
|
Precancerous Conditions | 2 | 2021 | 976 | 0.140 |
Why?
|
Pandemics | 4 | 2020 | 8703 | 0.140 |
Why?
|
Early Detection of Cancer | 3 | 2021 | 3236 | 0.140 |
Why?
|
Cholangiocarcinoma | 1 | 2023 | 578 | 0.140 |
Why?
|
Bile Duct Neoplasms | 1 | 2023 | 626 | 0.140 |
Why?
|
Biliary Tract Diseases | 1 | 2017 | 160 | 0.140 |
Why?
|
Disinfection | 1 | 2019 | 207 | 0.130 |
Why?
|
Adult | 27 | 2024 | 223044 | 0.130 |
Why?
|
Elasticity Imaging Techniques | 1 | 2021 | 398 | 0.130 |
Why?
|
Hyaluronic Acid | 1 | 2020 | 484 | 0.130 |
Why?
|
Blood Gas Monitoring, Transcutaneous | 1 | 2016 | 34 | 0.130 |
Why?
|
Gastric Bypass | 2 | 2015 | 820 | 0.130 |
Why?
|
Esophageal Perforation | 1 | 2016 | 65 | 0.130 |
Why?
|
China | 5 | 2020 | 2385 | 0.130 |
Why?
|
Equipment Design | 2 | 2022 | 3481 | 0.130 |
Why?
|
Female | 39 | 2024 | 396112 | 0.130 |
Why?
|
Blood Pressure Determination | 1 | 2020 | 647 | 0.130 |
Why?
|
Fiber Optic Technology | 1 | 2017 | 284 | 0.130 |
Why?
|
Intubation, Intratracheal | 2 | 2014 | 1303 | 0.130 |
Why?
|
Capnography | 1 | 2016 | 90 | 0.130 |
Why?
|
Tomography, X-Ray Computed | 6 | 2020 | 20659 | 0.120 |
Why?
|
Hemorrhage | 2 | 2019 | 3461 | 0.120 |
Why?
|
Esophageal Neoplasms | 2 | 2016 | 1661 | 0.120 |
Why?
|
Disclosure | 1 | 2021 | 756 | 0.120 |
Why?
|
Prediabetic State | 1 | 2021 | 548 | 0.120 |
Why?
|
Antibiotic Prophylaxis | 1 | 2020 | 644 | 0.120 |
Why?
|
Thermometers | 1 | 2015 | 42 | 0.120 |
Why?
|
Respiratory Rate | 1 | 2016 | 179 | 0.120 |
Why?
|
Lipase | 1 | 2017 | 320 | 0.120 |
Why?
|
Quality Indicators, Health Care | 1 | 2024 | 1806 | 0.110 |
Why?
|
Esophagogastric Junction | 1 | 2016 | 351 | 0.110 |
Why?
|
Ampulla of Vater | 1 | 2014 | 150 | 0.110 |
Why?
|
Guidelines as Topic | 1 | 2020 | 1394 | 0.110 |
Why?
|
Tidal Volume | 1 | 2016 | 519 | 0.110 |
Why?
|
Peritonitis | 1 | 2016 | 369 | 0.110 |
Why?
|
Oximetry | 1 | 2016 | 459 | 0.100 |
Why?
|
Triage | 1 | 2020 | 996 | 0.100 |
Why?
|
Jejunum | 1 | 2015 | 474 | 0.100 |
Why?
|
Evoked Potentials, Auditory | 1 | 2016 | 530 | 0.100 |
Why?
|
Risk Factors | 11 | 2024 | 74840 | 0.100 |
Why?
|
Feasibility Studies | 1 | 2024 | 5302 | 0.100 |
Why?
|
Blood Pressure | 2 | 2020 | 8532 | 0.100 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2010 | 4628 | 0.100 |
Why?
|
Dilatation, Pathologic | 1 | 2014 | 527 | 0.100 |
Why?
|
Hemobilia | 1 | 2012 | 18 | 0.100 |
Why?
|
Gastritis, Hypertrophic | 1 | 2012 | 9 | 0.100 |
Why?
|
Cutaneous Fistula | 1 | 2012 | 80 | 0.100 |
Why?
|
Hepatitis C | 1 | 2002 | 1597 | 0.100 |
Why?
|
Ageusia | 1 | 2012 | 18 | 0.100 |
Why?
|
BRCA2 Protein | 1 | 2017 | 800 | 0.100 |
Why?
|
Young Adult | 10 | 2020 | 59889 | 0.100 |
Why?
|
Attitude of Health Personnel | 2 | 2020 | 3925 | 0.100 |
Why?
|
Cystic Duct | 1 | 2011 | 17 | 0.100 |
Why?
|
Societies, Medical | 1 | 2024 | 3956 | 0.100 |
Why?
|
Gastric Fistula | 1 | 2012 | 73 | 0.100 |
Why?
|
Intestinal Fistula | 1 | 2012 | 146 | 0.100 |
Why?
|
Multimedia | 1 | 2012 | 76 | 0.100 |
Why?
|
Leiomyoma | 1 | 2016 | 643 | 0.090 |
Why?
|
Carcinoma in Situ | 1 | 2017 | 779 | 0.090 |
Why?
|
Pancreaticoduodenectomy | 1 | 2015 | 512 | 0.090 |
Why?
|
Bile Duct Diseases | 1 | 2011 | 99 | 0.090 |
Why?
|
Colonic Neoplasms | 2 | 2020 | 2531 | 0.090 |
Why?
|
Balloon Occlusion | 1 | 2012 | 129 | 0.090 |
Why?
|
Spectroscopy, Near-Infrared | 1 | 2016 | 750 | 0.090 |
Why?
|
Reproducibility of Results | 8 | 2023 | 20124 | 0.090 |
Why?
|
Hypertension | 1 | 2011 | 8626 | 0.090 |
Why?
|
Foreign-Body Migration | 1 | 2012 | 220 | 0.090 |
Why?
|
Physicians | 2 | 2024 | 4588 | 0.090 |
Why?
|
Depression | 1 | 2010 | 8237 | 0.090 |
Why?
|
Group Processes | 1 | 2012 | 224 | 0.090 |
Why?
|
Crohn Disease | 1 | 2023 | 2283 | 0.090 |
Why?
|
Diagnostic Imaging | 2 | 2021 | 3529 | 0.090 |
Why?
|
Anesthesia Recovery Period | 1 | 2011 | 155 | 0.090 |
Why?
|
Sensitivity and Specificity | 3 | 2020 | 14652 | 0.080 |
Why?
|
Liver Cirrhosis | 2 | 2021 | 1959 | 0.080 |
Why?
|
Gastrostomy | 1 | 2012 | 327 | 0.080 |
Why?
|
Cryosurgery | 1 | 2015 | 479 | 0.080 |
Why?
|
Alzheimer Disease | 5 | 2006 | 8730 | 0.080 |
Why?
|
Nursing Staff | 1 | 2010 | 113 | 0.080 |
Why?
|
Biopsy | 3 | 2021 | 6763 | 0.080 |
Why?
|
Pulmonary Veins | 1 | 2015 | 757 | 0.080 |
Why?
|
Gallstones | 1 | 2011 | 285 | 0.080 |
Why?
|
Esophagus | 1 | 2015 | 1037 | 0.080 |
Why?
|
Pathology | 1 | 2012 | 270 | 0.080 |
Why?
|
Pneumonia | 1 | 2020 | 2157 | 0.080 |
Why?
|
Equipment and Supplies | 1 | 2021 | 273 | 0.080 |
Why?
|
Salvage Therapy | 1 | 2015 | 1272 | 0.080 |
Why?
|
Incidence | 5 | 2023 | 21480 | 0.070 |
Why?
|
Treatment Outcome | 11 | 2024 | 65188 | 0.070 |
Why?
|
Mass Screening | 2 | 2021 | 5446 | 0.070 |
Why?
|
Hypotension | 1 | 2014 | 885 | 0.070 |
Why?
|
Alopecia | 1 | 2012 | 414 | 0.070 |
Why?
|
Ultrasonography, Interventional | 3 | 2020 | 1531 | 0.070 |
Why?
|
Lasers | 1 | 2021 | 951 | 0.070 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2022 | 10383 | 0.070 |
Why?
|
Blood Glucose | 1 | 2021 | 6424 | 0.070 |
Why?
|
Multivariate Analysis | 2 | 2019 | 12056 | 0.070 |
Why?
|
Tomography, Optical Coherence | 1 | 2019 | 2932 | 0.070 |
Why?
|
Regression Analysis | 1 | 2016 | 6322 | 0.070 |
Why?
|
Cohort Studies | 5 | 2021 | 41649 | 0.060 |
Why?
|
Diagnosis, Differential | 4 | 2017 | 12976 | 0.060 |
Why?
|
Hemodynamics | 1 | 2016 | 4184 | 0.060 |
Why?
|
Adipose Tissue | 1 | 2017 | 3312 | 0.060 |
Why?
|
Light | 1 | 2021 | 1365 | 0.060 |
Why?
|
Necrosis | 2 | 2020 | 1617 | 0.060 |
Why?
|
Time Factors | 5 | 2022 | 40065 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2020 | 9373 | 0.060 |
Why?
|
Heart Rate | 1 | 2016 | 4204 | 0.060 |
Why?
|
Fatigue | 1 | 2012 | 1549 | 0.060 |
Why?
|
Teaching | 1 | 2012 | 1169 | 0.060 |
Why?
|
Prothrombin | 2 | 2006 | 193 | 0.060 |
Why?
|
Liver | 2 | 2021 | 7562 | 0.060 |
Why?
|
Critical Illness | 1 | 2017 | 2744 | 0.060 |
Why?
|
Early Diagnosis | 2 | 2020 | 1187 | 0.050 |
Why?
|
Electrocardiography | 1 | 2016 | 6404 | 0.050 |
Why?
|
Blood-Borne Pathogens | 1 | 2002 | 51 | 0.050 |
Why?
|
Education, Medical, Undergraduate | 1 | 2012 | 1085 | 0.050 |
Why?
|
Diabetes Mellitus | 1 | 2021 | 5891 | 0.050 |
Why?
|
United States | 5 | 2024 | 72903 | 0.050 |
Why?
|
Predictive Value of Tests | 4 | 2021 | 15398 | 0.050 |
Why?
|
Competency-Based Education | 1 | 2024 | 226 | 0.050 |
Why?
|
Liability, Legal | 1 | 2024 | 209 | 0.050 |
Why?
|
Adolescent | 6 | 2020 | 88835 | 0.050 |
Why?
|
Rhode Island | 1 | 2002 | 351 | 0.050 |
Why?
|
Anti-Bacterial Agents | 1 | 2020 | 7478 | 0.050 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 2023 | 307 | 0.050 |
Why?
|
Apolipoproteins E | 2 | 2006 | 1458 | 0.040 |
Why?
|
Asymptomatic Diseases | 1 | 2024 | 586 | 0.040 |
Why?
|
Spectrum Analysis | 1 | 2023 | 443 | 0.040 |
Why?
|
Case Management | 1 | 2002 | 277 | 0.040 |
Why?
|
Ribavirin | 1 | 2002 | 395 | 0.040 |
Why?
|
Electroencephalography | 1 | 2016 | 6273 | 0.040 |
Why?
|
Capillaries | 2 | 2002 | 755 | 0.040 |
Why?
|
Health Surveys | 1 | 2010 | 4056 | 0.040 |
Why?
|
Adenocarcinoma | 2 | 2015 | 6364 | 0.040 |
Why?
|
Weight Loss | 1 | 2012 | 2710 | 0.040 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2006 | 3807 | 0.040 |
Why?
|
Mucous Membrane | 1 | 2023 | 657 | 0.040 |
Why?
|
Blood-Brain Barrier | 1 | 2006 | 1037 | 0.040 |
Why?
|
Follow-Up Studies | 4 | 2019 | 39193 | 0.040 |
Why?
|
Cerebrovascular Disorders | 1 | 2006 | 1470 | 0.040 |
Why?
|
Postoperative Hemorrhage | 1 | 2023 | 413 | 0.040 |
Why?
|
Clinical Alarms | 1 | 2020 | 59 | 0.040 |
Why?
|
Postoperative Complications | 2 | 2024 | 15747 | 0.040 |
Why?
|
Equipment Reuse | 1 | 2019 | 45 | 0.040 |
Why?
|
Interferons | 1 | 2002 | 714 | 0.040 |
Why?
|
Prevalence | 3 | 2017 | 15842 | 0.040 |
Why?
|
Growth Substances | 1 | 2001 | 758 | 0.040 |
Why?
|
Ecosystem | 1 | 2023 | 488 | 0.040 |
Why?
|
Laminin | 1 | 2000 | 404 | 0.040 |
Why?
|
Acute Disease | 2 | 2021 | 7232 | 0.040 |
Why?
|
Computer Systems | 1 | 2019 | 466 | 0.040 |
Why?
|
Substance Abuse, Intravenous | 1 | 2002 | 531 | 0.040 |
Why?
|
Choroid Plexus | 1 | 2001 | 250 | 0.040 |
Why?
|
Cerebrospinal Fluid | 1 | 2001 | 539 | 0.040 |
Why?
|
Databases, Factual | 3 | 2018 | 8067 | 0.040 |
Why?
|
Checklist | 1 | 2024 | 848 | 0.040 |
Why?
|
Body Fluids | 1 | 2019 | 321 | 0.040 |
Why?
|
Immunohistochemistry | 5 | 2006 | 11022 | 0.040 |
Why?
|
Chronic Disease | 1 | 2012 | 9347 | 0.030 |
Why?
|
Teaching Rounds | 1 | 2021 | 280 | 0.030 |
Why?
|
Endoscopes | 1 | 2017 | 168 | 0.030 |
Why?
|
Debridement | 1 | 2019 | 495 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 4 | 2020 | 36532 | 0.030 |
Why?
|
Patients | 1 | 2023 | 910 | 0.030 |
Why?
|
Carboxypeptidases | 1 | 1996 | 121 | 0.030 |
Why?
|
Brain Chemistry | 1 | 2000 | 952 | 0.030 |
Why?
|
Atrial Fibrillation | 1 | 2015 | 5189 | 0.030 |
Why?
|
Proton Pump Inhibitors | 1 | 2021 | 553 | 0.030 |
Why?
|
Organoids | 1 | 2022 | 739 | 0.030 |
Why?
|
Fasting | 1 | 2021 | 1606 | 0.030 |
Why?
|
Natural Language Processing | 1 | 2024 | 1203 | 0.030 |
Why?
|
Digestive System Surgical Procedures | 1 | 2020 | 580 | 0.030 |
Why?
|
Patient Discharge | 1 | 2008 | 3461 | 0.030 |
Why?
|
Fibrosis | 1 | 2021 | 2070 | 0.030 |
Why?
|
Blood Transfusion | 1 | 2021 | 1297 | 0.030 |
Why?
|
Area Under Curve | 1 | 2018 | 1638 | 0.030 |
Why?
|
Microcirculation | 1 | 1999 | 1280 | 0.030 |
Why?
|
Prosthesis Failure | 1 | 2019 | 1191 | 0.030 |
Why?
|
Patient Readmission | 1 | 2008 | 3286 | 0.030 |
Why?
|
Internationality | 1 | 2019 | 1007 | 0.030 |
Why?
|
Observer Variation | 1 | 2020 | 2615 | 0.030 |
Why?
|
Basement Membrane | 2 | 2006 | 349 | 0.030 |
Why?
|
Sus scrofa | 1 | 2015 | 430 | 0.030 |
Why?
|
Cicatrix | 1 | 2019 | 798 | 0.030 |
Why?
|
Gastric Mucosa | 1 | 2016 | 602 | 0.030 |
Why?
|
Propensity Score | 1 | 2021 | 1968 | 0.030 |
Why?
|
Esophagoscopy | 1 | 2015 | 398 | 0.030 |
Why?
|
Nursing Homes | 1 | 2020 | 1084 | 0.030 |
Why?
|
Evidence-Based Practice | 1 | 2017 | 500 | 0.030 |
Why?
|
Anesthesia, Inhalation | 1 | 2013 | 216 | 0.030 |
Why?
|
Mutation | 1 | 2017 | 30198 | 0.020 |
Why?
|
Comparative Effectiveness Research | 1 | 2017 | 714 | 0.020 |
Why?
|
Antigens, Surface | 1 | 1996 | 1617 | 0.020 |
Why?
|
Education, Medical, Graduate | 1 | 2024 | 2418 | 0.020 |
Why?
|
Severity of Illness Index | 2 | 2023 | 15880 | 0.020 |
Why?
|
Prosthesis Design | 1 | 2018 | 2105 | 0.020 |
Why?
|
Anastomosis, Surgical | 1 | 2015 | 990 | 0.020 |
Why?
|
Disease Outbreaks | 1 | 2020 | 1759 | 0.020 |
Why?
|
Lithotripsy | 1 | 2011 | 136 | 0.020 |
Why?
|
ROC Curve | 1 | 2018 | 3620 | 0.020 |
Why?
|
Heterozygote | 1 | 2017 | 2794 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2020 | 22223 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2002 | 3050 | 0.020 |
Why?
|
Cerebrovascular Circulation | 1 | 1999 | 2674 | 0.020 |
Why?
|
Heart Atria | 1 | 2015 | 1363 | 0.020 |
Why?
|
Treatment Failure | 1 | 2015 | 2652 | 0.020 |
Why?
|
Recurrence | 1 | 2021 | 8501 | 0.020 |
Why?
|
Problem-Based Learning | 1 | 2012 | 360 | 0.020 |
Why?
|
Focus Groups | 1 | 2014 | 1459 | 0.020 |
Why?
|
Patient Selection | 1 | 2020 | 4255 | 0.020 |
Why?
|
Bacteria | 1 | 2019 | 2209 | 0.020 |
Why?
|
Length of Stay | 1 | 2021 | 6485 | 0.020 |
Why?
|
Hippocampus | 1 | 2000 | 3775 | 0.020 |
Why?
|
Enteral Nutrition | 1 | 2012 | 803 | 0.020 |
Why?
|
Hospital Mortality | 1 | 2020 | 5343 | 0.020 |
Why?
|
Amyloid beta-Peptides | 1 | 2000 | 3896 | 0.020 |
Why?
|
Postmortem Changes | 1 | 2006 | 119 | 0.020 |
Why?
|
Hyperlipidemias | 1 | 2011 | 770 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2020 | 12437 | 0.020 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2012 | 1127 | 0.020 |
Why?
|
Swine | 1 | 2015 | 5988 | 0.010 |
Why?
|
Cooperative Behavior | 1 | 2012 | 1509 | 0.010 |
Why?
|
Fatty Liver | 1 | 2011 | 807 | 0.010 |
Why?
|
Boston | 1 | 2017 | 9338 | 0.010 |
Why?
|
Logistic Models | 1 | 2019 | 13266 | 0.010 |
Why?
|
Software | 1 | 2018 | 4462 | 0.010 |
Why?
|
Factor VIII | 1 | 2006 | 347 | 0.010 |
Why?
|
Radiography | 1 | 2015 | 6919 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2021 | 7425 | 0.010 |
Why?
|
Radiosurgery | 1 | 2013 | 1328 | 0.010 |
Why?
|
Program Evaluation | 1 | 2012 | 2499 | 0.010 |
Why?
|
Registries | 1 | 2019 | 8297 | 0.010 |
Why?
|
Pilot Projects | 1 | 2016 | 8733 | 0.010 |
Why?
|
Comorbidity | 1 | 2017 | 10563 | 0.010 |
Why?
|
Body Weight | 1 | 2013 | 4622 | 0.010 |
Why?
|
Muscle, Smooth | 1 | 2006 | 931 | 0.010 |
Why?
|
Arachnoid | 1 | 2001 | 50 | 0.010 |
Why?
|
Patient Care Team | 1 | 2012 | 2517 | 0.010 |
Why?
|
Models, Statistical | 1 | 2015 | 5089 | 0.010 |
Why?
|
Receptors, Fibroblast Growth Factor | 1 | 2001 | 192 | 0.010 |
Why?
|
Vimentin | 1 | 2001 | 258 | 0.010 |
Why?
|
Neurons | 1 | 1999 | 9525 | 0.010 |
Why?
|
Obesity | 1 | 2021 | 13076 | 0.010 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 2001 | 754 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2020 | 26318 | 0.010 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2001 | 594 | 0.010 |
Why?
|
Animals | 2 | 2024 | 168764 | 0.010 |
Why?
|
Endothelial Growth Factors | 1 | 2001 | 680 | 0.010 |
Why?
|
Massachusetts | 1 | 2011 | 8875 | 0.010 |
Why?
|
Lymphokines | 1 | 2001 | 911 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2006 | 6203 | 0.010 |
Why?
|
Solubility | 1 | 1999 | 1078 | 0.010 |
Why?
|
Disease Progression | 2 | 2006 | 13632 | 0.010 |
Why?
|
Pteroylpolyglutamic Acids | 1 | 1996 | 9 | 0.010 |
Why?
|
gamma-Glutamyl Hydrolase | 1 | 1996 | 8 | 0.010 |
Why?
|
Polyglutamic Acid | 1 | 1996 | 46 | 0.010 |
Why?
|
Prognosis | 1 | 2017 | 29922 | 0.010 |
Why?
|
Cell Fractionation | 1 | 1996 | 243 | 0.010 |
Why?
|
Glutamate Carboxypeptidase II | 1 | 1996 | 90 | 0.010 |
Why?
|
Hydrolases | 1 | 1996 | 146 | 0.010 |
Why?
|
Amyloid | 1 | 2001 | 853 | 0.010 |
Why?
|
Child | 1 | 2023 | 80564 | 0.010 |
Why?
|
Fibroblast Growth Factors | 1 | 2001 | 871 | 0.010 |
Why?
|
Hydrocephalus | 1 | 2001 | 762 | 0.010 |
Why?
|
Body Mass Index | 1 | 2011 | 13039 | 0.010 |
Why?
|
Substrate Specificity | 1 | 1996 | 1752 | 0.010 |
Why?
|
Brain | 1 | 1999 | 27171 | 0.010 |
Why?
|
Prefrontal Cortex | 1 | 2002 | 2224 | 0.010 |
Why?
|
Reference Values | 1 | 1999 | 4908 | 0.010 |
Why?
|
Hydrogen-Ion Concentration | 1 | 1996 | 2477 | 0.010 |
Why?
|
Cerebral Cortex | 1 | 2006 | 5767 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2001 | 3513 | 0.010 |
Why?
|
Methotrexate | 1 | 1996 | 1722 | 0.010 |
Why?
|
Folic Acid | 1 | 1996 | 1338 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 1996 | 6113 | 0.000 |
Why?
|
Genotype | 1 | 2002 | 13024 | 0.000 |
Why?
|
Cell Membrane | 1 | 1996 | 3634 | 0.000 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2002 | 8923 | 0.000 |
Why?
|
Prostatic Neoplasms | 1 | 1996 | 11083 | 0.000 |
Why?
|